Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery

Journal of Drug Targeting

Volumn 16, Issue 9, 2008, Pages 639-648

  Bi, Ru ^a   Shao, Wei ^a   Wang, Qun ^b   Zhang, Na ^a  

^a SHANDONG UNIVERSITY   (China)

^b University of Kansas   (United States)

Author keywords

Dry powder inhalation (DPI); Insulin (Ins); Intratracheal instillation; Liposomes; Pulmonary delivery; Spray freeze drying (SFD)

Indexed keywords

INSULIN; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATMOSPHERIC PRESSURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG FORMULATION; DRUG INSTILLATION; DRUG STABILITY; DRY POWDER; FREEZE DRYING; HYPOGLYCEMIA; IN VIVO STUDY; MALE; MOISTURE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RAT;

ADMINISTRATION, INHALATION; ANIMALS; BLOOD GLUCOSE; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FREEZE DRYING; INSULIN; LIPOSOMES; MALE; POWDERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 55849123635     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860802201134     Document Type: Article

References (41)

1. Agu, RU, Ugwoke, MI, Armand, M., Kinget, R. and Verbeke, N. (2001) The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir Res, 2, pp. 198-209.
2. Azarmi, S., Tao, X., Chen, H., Wang, Z., Finlay, WH, Lobenberg, R. and Roa, WH (2006) Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Int J Pharm, 319, pp. 155-161.
3. Bi, R. and Zhang, N. (2007) Liposomes as a carrier for pulmonary delivery of peptides and proteins. J Biomed Nanotech, 3, pp. 332-341.
4. Bridges, PA and Taylor, KM (2000) An investigation of some of the factors influencing the jet nebulisation of liposomes. Int J Pharm, 204, pp. 69-79.
5. Cilek, A., Celebi, N., Tirnaksiz, F. and Tay, A. (2005) A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats. Int J Pharm, 298, pp. 176-185.
6. Cryan, SA (2005) Carrier-based strategies for targeting protein and peptide drugs to the lungs. AAPS J, 7, pp. E20-E41.
7. Edwards, DA, Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, ML, Mintzes, J., Deaver, D., Lotan, N. and Langer, R. (1997) Large porous particles for pulmonary drug delivery. Science, 276, pp. 1868-1871.
8. Engstrom, JD, Simpson, DT, Cloonan, C., Lai, ES, Williams III, RO, Barrie Kitto, G and Johnston, KP (2007) Stable high surface area lactate dehydrogenase particles produced by spray freezing into liquid nitrogen. Eur J Pharm Biopharm, 65, pp. 163-174.
9. Gannslen, M. (1925) Uber inhalation von insulin. KlinWochenschr, pp. 4-71.
10. Gupta, R. and Byron, PR (2000) Physical characterization of large porous particles for inhalation. Pharm Res, 17, pp. 1437-1438.
11. Jani, R., Triplitt, C., Reasner, C. and Defronzo, RA (2007) First approved inhaled insulin therapy for diabetes mellitus. Expert Opin Drug Deliv, 4, pp. 63-76.
12. Joshi, M. and Misra, A. (2003) Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung. Clin Exp Pharmacol Physiol, 30, pp. 153-156.
13. Jurima-Romet, M. and Shek, PN (1991) Lung uptake of liposome-entrapped glutathione after intratracheal administration. J Pharm Pharmacol, 43, pp. 6-10.
14. Kumar, TR, Soppimath, K. and Nachaegari, SK (2006) Novel delivery technologies for protein and peptide therapeutics. Curr Pharm Biotechnol, 7, pp. 261-276.
15. Leung, KKM, Bridges, PA and Taylor, KMG (1996) The stability of liposomes to ultrasonic nebulisation. Int J Pharm, 145, pp. 95-102.
16. Lu, D. and Hickey, AJ (2005) Liposomal dry powders as aerosols for pulmonary delivery of proteins. AAPS PharmSciTech, 6, pp. 641-648.
17. Maa, YF, Nguyen, PA, Sweeney, T., Shire, SJ and Hsu, CC (1999) Protein inhalation powders: Spray drying vs spray freeze drying. Pharm Res, 16, pp. 249-254.
18. Maa, YF, Ameri, M., Shu, C., Payne, LG and Chen, D. (2004) Influenza vaccine powder formulation development: Spray-freeze-drying and stability evaluation. J Pharm Sci, 93, pp. 1912-1923.
19. Mitchell, JP, Nagel, MW, Wiersema, KJ and Doyle, CC (2003) Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: Comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer. AAPS PharmSciTech, 4, p. E54.
20. Mitra, R., Pezron, I., Li, Y. and Mitra, AK (2001) Enhanced pulmonary delivery of insulin by lung lavage fluid and phospholipids. Int J Pharm, 217, pp. 25-31.
21. Miyajima, K. (1997) Role of saccharides for the freeze-thawing and the freeze-drying of liposome. Adv Drug Deliv Rev, 24, pp. 151-159.
22. Niven, R. and Schreier, H. (1990) Nebulization of liposomes. I. Effects of lipid composition. Pharm Res, 7, pp. 1127-1133.
23. Niven, R., Speer, M. and Schreier, H. (1991) Nebulization of liposomes. II. The effects of size and modeling of solute release profiles. Pharm Res, 8, pp. 217-221.
24. Niven, R., Carvajal, TM and Schreier, H. (1992) Nebulization of liposomes. III. The effects of operating conditions and local environment. Pharm Res, 9, pp. 515-520.
25. Park, SH, Kwon, JH, Lim, SH, Park, HW and Kim, CW (2007) Characterization of human insulin microcrystals and their absorption enhancement by protease inhibitors in rat lungs. Int J Pharm, 339, pp. 205-212.
26. Patton, J., Bukar, J. and Nagarajan, S. (1999) Inhaled insulin. Adv Drug Deliv Rev, 35, pp. 235-247.
27. Patton, JS, Bukar, JG and Eldon, MA (2004) Clinical pharmacokinetics and pharmacodynamics of inhaled insulin. Clin Pharmacokinet, 43, pp. 781-801.
28. Pinto-Alphandary, H., Andremont, A. and Couvreur, P. (2000) Targeted delivery of antibiotics using liposomes and nanoparticles: Research and applications. Int J Antimicrob Agents, 13, pp. 155-168.
29. Pitcairn, G., Reader, S., Pavia, D. and Newman, S. (2005) Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler. J Aerosol Med, 18, pp. 264-272.
30. Radwan, MA and Aboul-Enein, HY (2002) The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats. J Microencapsul, 19, pp. 225-235.
31. Scheuch, G., Kohlhaeufl, MJ and Siekeier, PBR (2006) Clinical perspectives on pulmonary systemic and macromolecular delivery. Adv Drug Deliv Rev, 58, pp. 996-1008.
32. Scott-Moncrieff, JC, Shao, ZZ and Mitra, AK (1994) Enhancement of intestinal insulin absorption by bile salt-fatty acid mixed micelles in dogs. J Pharm Sci, 83, pp. 1465-1469.
33. Shah, SP and Misra, A. (2004) Liposomal amikacin dry powder inhaler: Effect of fines on in vitro performance. AAPS PharmSciTech, 5, pp. 1-7.
34. Sweeney, LG, Wang, Z., Loebenberg, R., Wong, JP, Lange, CF and Finlay, WH (2005) Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery. Int J Pharm, 305, pp. 180-185.
35. Vanbever, R., Mintzes, JD, Wang, J., Nice, J., Chen, D., Batycky, R., Langer, R. and Edwards, DA (1999) Formulation and physical characterization of large porous particles for inhalation. Pharm Res, 16, pp. 1735-1742.
36. van Drooge, DJ, Hinrichs, WL, Dickhoff, BH, Elli, MN, Visser, MR, Zijlstra, GS and Frijlink, HW (2005) Spray freeze drying to produce a stable delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation. Eur J Pharm Sci, 26, pp. 231-240.
37. Wigley, FM, Londono, JH and Wood, JH (1971) Insulin across respiratory mucosa by aerosol delivery. Diabetes, 20, pp. 552-556.
38. Yamamoto, H., Kuno, Y., Sugimoto, S., Takeuchi, H. and Kawashima, Y. (2005) Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release, 102, pp. 373-381.
39. Zhang, X., Zhang, Q. and Qi, XR (2001) Structure characteristics of insulin liposomes. Acta Pharm Sin, 36, pp. 448-451.
40. Zhang, N., Ping, QN, Huang, GH and Xu, WF (2005) Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm, 294, pp. 247-259.
41. Zeng, XM, Martin, GP and Marriott, C. (1995) The controlled delivery of drugs to the lung. Int J Pharm, 124, pp. 149-164.